Diferencia entre revisiones de «Hiperpirexia»

▲* [[Síndrome de Kawasaki]].<ref name="MDMA-Hyperpyrexia systematic review">{{cite journal | autor = Grunau BE, Wiens MO, Brubacher JR | title = Dantrolene in the treatment of MDMA-related hyperpyrexia: a systematic review | journal = Canadian Journal of Emergency Medicine | volume = 12 | issue = 5 | pages = 435–42 | date = September 2010 | pmid = 20880437 | doi = 10.1017/s1481803500012598 | quote = Dantrolene may also be associated with improved survival and reduced complications, especially in patients with extreme (≥ 42°C) or severe (≥ 40°C) hyperpyrexia }}</ref><ref name="Neurobiology of hyperthermia">{{cite book | editor=Sharma HS | title=Neurobiology of Hyperthermia | date=2007 | publisher=Elsevier | isbn=9780080549996 | pages=175–177, 485 | edition=1st | url=https://books.google.com/books?id=Vk1UTlmEwrQC&pg=485#v=onepage&q=hyperpyrexia%20core%20temperature&f=false | access-date=19 November 2016| archive-url=https://web.archive.org/web/20170908174330/https://books.google.com/books?id=Vk1UTlmEwrQC&pg=485#v=onepage&q=hyperpyrexia%20core%20temperature&f=false | archive-date=8 septiembre 2017 }}</ref><ref name=H2015Chp23>{{cita libro |título=Harrison's Principles of Internal Medicine 19/E (Vol.1 & Vol.2)|año=2015|editorial=McGraw Hill Professional|isbn=9780071802161|capítulo = cap.23:Fever |edición=19}}</ref> <ref name=EM01/> <ref name=H2015Chp23/> <ref name="Marx 2006 2506">Marx 2006, p. 2506</ref> <ref name=EM01>{{cite journal | autor = McGugan EA | title = Hyperpyrexia in the emergency department | journal = Emergency Medicine | volume = 13 | issue = 1 | pages = 116–20 | date = March 2001 | pmid = 11476402 | doi = 10.1046/j.1442-2026.2001.00189.x }}</ref> <ref>[https://www.elsevier.es/es-revista-revista-medica-clinica-las-condes-202-articulo-hipertermia-maligna-S071686401170431X ''Hipertermia maligna''.] Emergencias vitales en la práctica clínica. Páginas 310-315 (mayo 2011). Autor: Jaime Escobar. Consultado el 18 de agosto de 2019.</ref>